Jia Qi Selected Research

Angiotensin II

10/2020	Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
1/2020	Targeting HSP90 attenuates angiotensin II-induced adventitial remodelling via suppression of mitochondrial fission.
1/2015	Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac Fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jia Qi Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 06/2011
9	Inflammation (Inflammations) 01/2024 - 02/2013
9	Ischemia 01/2021 - 01/2010
8	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2023 - 01/2018
6	Infertility (Sterility) 03/2024 - 01/2019
6	Hypertension (High Blood Pressure) 01/2024 - 01/2016
6	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2016
5	Insulin Resistance 01/2021 - 01/2018
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2010
4	Fibrosis (Cirrhosis) 01/2022 - 01/2015
4	Infarction (Infarctions) 01/2021 - 11/2010
4	Ischemic Stroke 01/2015 - 01/2010
3	Stomach Neoplasms (Stomach Cancer) 03/2024 - 02/2022
3	Obesity 01/2024 - 01/2023
3	Heart Failure 01/2022 - 01/2016
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 10/2017
3	Carcinogenesis 05/2019 - 03/2016
3	Hypoxia (Hypoxemia) 01/2019 - 02/2014
3	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2015
2	Acidosis 01/2024 - 01/2013
2	Anovulation 01/2024 - 10/2019
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2022
2	Cardiotoxicity 01/2023 - 01/2022
2	Vascular Remodeling 01/2022 - 10/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2018
2	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2020
2	Hyperglycemia 01/2021 - 10/2020
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 05/2015
2	Stroke (Strokes) 01/2021 - 11/2010
2	Abdominal Aortic Aneurysm 01/2020 - 04/2015
2	Acute Kidney Injury (Acute Renal Failure) 09/2018 - 03/2017
2	Cerebral Infarction 01/2014 - 01/2010
1	Iron Deficiencies 01/2024
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2024
1	Hyperandrogenism 01/2024
1	Glucose Intolerance 01/2024
1	Poisoning 01/2024
1	Wounds and Injuries (Trauma) 12/2023
1	Hyperlipidemias (Hyperlipidemia) 10/2023
1	Non-alcoholic Fatty Liver Disease 10/2023
1	Hypertrophy 10/2023
1	Tertiary Lymphoid Structures 07/2023
1	Overweight 01/2023
1	Adenocarcinoma 01/2023
1	Adenocarcinoma of Lung 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022

Drug/Important Bio-Agent (IBA)

8	Therapeutic UsesIBA 10/2023 - 01/2010
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2016
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2017
5	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 01/2021 - 01/2014
4	Long Noncoding RNAIBA 03/2024 - 01/2019
4	AntioxidantsIBA 12/2023 - 01/2010
4	CytokinesIBA 12/2023 - 06/2011
4	LipidsIBA 10/2023 - 02/2020
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 05/2015
4	leonurineIBA 09/2018 - 01/2010
3	Capsules (Microcapsules)IBA 10/2023 - 11/2020
3	Immune Checkpoint InhibitorsIBA 07/2023 - 01/2023
3	Estradiol (Delestrogen)FDA LinkGeneric 01/2023 - 01/2019
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2015
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2015
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021 - 01/2018
3	Angiotensin IIIBA 10/2020 - 01/2015
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2016
2	Hormones (Hormone)IBA 01/2024 - 01/2021
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2023 - 06/2022
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 06/2022
2	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 06/2022
2	DiureticsIBA 01/2023 - 06/2022
2	Angiotensin Receptor AntagonistsIBA 01/2023 - 06/2022
2	LigandsIBA 01/2023 - 06/2011
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 10/2017
2	Sirtuin 1IBA 01/2022 - 01/2018
2	Tight Junction ProteinsIBA 01/2021 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2018 - 10/2017
2	Phosphotransferases (Kinase)IBA 04/2015 - 12/2014
2	Neuroprotective AgentsIBA 11/2010 - 01/2010
1	Dietary IronIBA 01/2024
1	ferrostatin-1IBA 01/2024
1	SulfonamidesIBA 01/2024
1	IronIBA 01/2024
1	Oxidants (Oxidizing Agents)IBA 12/2023
1	Testosterone (Sustanon)FDA Link 01/2023
1	FructoseIBA 01/2023
1	InflammasomesIBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	CholesterolIBA 01/2023
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022
1	Plasminogen Activator Inhibitor 1IBA 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	AnthracyclinesIBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022

Therapy/Procedure

5	Therapeutics 01/2023 - 01/2017
4	Drug Therapy (Chemotherapy) 01/2023 - 12/2014
4	Ultrasonic Therapy 01/2019 - 01/2016
2	Immunotherapy 01/2023 - 01/2023
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 12/2014
1	Injections 03/2024